Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Li, Ge ^a   Peskind, Elaine R ^a,b   Millard, Steven P ^b   Chi, Peter ^a   Sokal, Izabela ^a   Yu, Chang En ^a,b   Bekris, Lynn M ^a,b   Raskind, Murray A ^a,b   Galasko, Douglas R ^c   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RECALL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COGNITION; CROSS-SECTIONAL STUDY; GENETICS; LONGITUDINAL STUDY; MEMORY; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; YOUNG ADULT;

EID: 65549104991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005424     Document Type: Article

References (25)

1. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, et al. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23: 6690-4.
2. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-69.
3. Miyajima F, Ollier W, Mayes A, Jackson A, Thacker N, et al. (2008) Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav 7: 411-7.
4. Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, et al. (2006) BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59: 812-5.
5. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-8.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-44.
7. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, et al. (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 129: 526-9.
8. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-8.
9. Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, et al. (2008) Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis 13: 255-66.
10. Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, et al. (1998) Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Arch Gen Psychiatry 55: 995-1000.
11. Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, et al. (1993) Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 107: 926-40.
12. Wechsler D, Stone CP (1983) Manual: Wechsler Memory Scale. New York: Psychological Corporation.
13. Gomez RG, White DA (2006) Using verbal fluency to detect very mild dementia of the Alzheimer type. Arch Clin Neuropsychol 21: 771-5.
14. Reitan RW, D. (1985) The Halstead-Reitan neuropsychological test battery. Tucson: Neuropsychology Press.
15. Milliken JK, Edland SD (2000) Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note. Stat Med 19: 1617-29.
16. Corporation I, S-PLUS. 2008, Insightful Corporation: seattle, WA.
17. Team R D C, R: A language and environment for statistical computing. 2008, R Foundation for Statistical Computing: Vienna, Austria.
18. Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, et al. (2007) CSF tau/ Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology 69: 631-9.
19. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, et al. (2007) Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64: 343-9.
20. Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl. pp 277-90.
21. Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, et al. (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis 7: 125-33; discussion 73-80.
22. Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, et al. (2006) Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 21: 9-15.
23. Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, et al. (2007) BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41: 387-94.
24. Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, et al. (2006) Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 113: 1217-24.
25. Sohrabji F, Lewis DK (2006) Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 27: 404-14.